These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38102745)

  • 1. Comorbidities associated with symptoms of subjective cognitive decline in individuals aged 45-64.
    Monahan Z; Heath J; Santos AD; Ford A; Hartwell M
    J Osteopath Med; 2024 Jun; 124(6):277-283. PubMed ID: 38102745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.
    Strand BH; Knapskog AB; Persson K; Edwin TH; Amland R; Mjørud M; Bjertness E; Engedal K; Selbæk G
    PLoS One; 2018; 13(9):e0204436. PubMed ID: 30240425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating disparity of subjective cognitive decline between male veterans and non-veterans in the United States using propensity score matching estimation: A behavioral risk factor surveillance system survey cross-sectional study.
    Ifebirinachi C; Park MS; Kim ST
    PLoS One; 2024; 19(9):e0310102. PubMed ID: 39269972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective Cognitive Decline Among Adults Aged ≥45 Years - United States, 2015-2016.
    Taylor CA; Bouldin ED; McGuire LC
    MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(27):753-757. PubMed ID: 30001562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
    Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
    Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation Between Smoking Status and Subjective Cognitive Decline in Middle Age and Older Adults: A Cross-Sectional Analysis of 2019 Behavioral Risk Factor Surveillance System Data.
    Rajczyk JI; Ferketich A; Wing JJ
    J Alzheimers Dis; 2023; 91(1):215-223. PubMed ID: 36373317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying latent comorbidity patterns in adults with perceived cognitive impairment: Network findings from the behavioral risk factor surveillance system.
    Ramos-Vera C; Saintila J; O'Diana AG; Calizaya-Milla YE
    Front Public Health; 2022; 10():981944. PubMed ID: 36203679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fay-Herriot Model for Estimating Subjective Cognitive Decline among Military Veterans.
    McDaniel JT; McDermott RJ; Schneider T
    J Prev Alzheimers Dis; 2021; 8(4):457-461. PubMed ID: 34585220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline.
    Ismail Z; McGirr A; Gill S; Hu S; Forkert ND; Smith EE
    J Alzheimers Dis; 2021; 80(1):459-469. PubMed ID: 33554909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A latent class analysis of cognitive decline in US adults, BRFSS 2015-2020.
    Snead R; Dumenci L; Jones RM
    BMC Public Health; 2022 Aug; 22(1):1560. PubMed ID: 35974367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Ethnic Differences in Subjective Cognitive Decline - United States, 2015-2020.
    Wooten KG; McGuire LC; Olivari BS; Jackson EMJ; Croft JB
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(10):249-255. PubMed ID: 36893045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic disparities in subjective cognitive decline: a closer look, United States, 2015-2018.
    Gupta S
    BMC Public Health; 2021 Jun; 21(1):1173. PubMed ID: 34162356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
    J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS).
    Chen Z; Wong R
    Curr Alzheimer Res; 2024; 20(11):802-810. PubMed ID: 38409714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.